$165.935
1.275[0.77%]
Last update: 3:14PM Get Real Time Here
AbbVie Stock (NYSE:ABBV), Quotes and News Summary
AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.
| Open | $164.930 |
| Close | - |
| Volume / Avg. | 3.241M / 5.632M |
| Day Range | 163.260 - 166.600 |
| 52 Wk Range | 130.960 - 182.890 |
| Market Cap | $293.812B |
| P/E Ratio | 60.537 |
| Dividend Yield | 3.770% |
| Exchange | NYSE |
| RSI | 39 |
| Short Interest | 0.74% |
| Days to Cover | 2.25 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Abbvie Inc
Sector
Health Care
Industry
Biotechnology
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AbbVie (ABBV) stock?
You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.
Who are AbbVie's (ABBV) competitors?
Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for AbbVie (ABBV) stock?
The latest price target for AbbVie (NYSE: ABBV) was reported by Barclays on Wednesday, March 27, 2024. The analyst firm set a price target for 195.00 expecting ABBV to rise to within 12 months (a possible 17.52% upside). 24 analyst firms have reported ratings in the last year.
Current Stock Price for AbbVie (ABBV)?
The stock price for AbbVie (NYSE: ABBV) is $165.935 last updated Today at April 19, 2024 at 3:14 PM EDT.
Does AbbVie (ABBV) pay a dividend?
A quarterly cash dividend of $1.55 per share of Class A Common Stock. The quarterly cash dividend was payable on May 15, 2024 to stockholders of record on April 12, 2024.
When is AbbVie (NYSE:ABBV) reporting earnings?
AbbVie’s Q1 earnings are confirmed for Friday, April 26, 2024.
Is AbbVie (ABBV) going to split?
There is no upcoming split for AbbVie.
What sector and industry does AbbVie (ABBV) operate in?
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.